Hepatitis C Virus And TherapeuticsGlobal Industry Analysts
April 1, 2009
466 Pages - SKU: GJOB2271642
More Global Hepatitis reports
Blood: The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products by Kalorama Information
The global blood industry has experienced strong growth in recent years and although this brisk expansion will slow somewhat as products continue to mature ...
World Market for Molecular Diagnostics, 5th. Edition (Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas) by Kalorama Information
Molecular diagnostics is becoming a dominant platform in clinical medicine and represents one of the fastest growing segments of the IVD market. As analyst Shara ...
PCPs in an IFN-Free World: How Will the Availability of Safer and More Effective Oral Therapies Impact the Role of PCPs in Treating HCV Patients? by Decision Resources
Currently, HCV patients are treated with weekly subcutaneous injections of interferon-alpha and twice-daily oral ribavirin, although patients with HCV genotype-1 infections may ...
Global Hepatitis Drugs Market 2011-2015 by Infiniti Research LimitedSee all reports like this >>
TechNavio's analysts forecast the Global Hepatitis Drugs market to grow at a CAGR of 12.42 percent over the period 2011-2015. One of the key ...
We can help you find what you need. Call us or write us:
Need help in your search?
- PharmaPoint: Hepatitis C Virus - Current and Future Players
- Hepatitis B – Pipeline Review, H1 2013
- Travel Vaccines Market to 2019 - Hepatitis A, Japanese Encephalitis and Meningococcal Vaccine Segments to Drive Growth
- The Hepatitis C Market Outlook to 2022
- EpiCast Report: Hepatitis C Virus - Epidemiology Forecast to 2022